Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

Hair loss treatment caused more hair loss in a man.

CT60 polymorphism might increase the risk of Alopecia Areata.

Genetic testing for hairless gene mutations is crucial to correctly diagnose and treat atrichia with papular lesions.

Bmpr2 and Acvr2a receptors are crucial for hair retention and color.

Adult female acne requires personalized treatment and maintenance to prevent relapse.

A dog in Germany was successfully treated for a rare bacterial infection without spreading it to humans.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Fibroblasts are crucial for tissue repair and inflammation, and understanding them can help treat fibrotic diseases.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Microneedles are effective for painless drug delivery and promoting wound healing and tissue regeneration.

Injecting lentiviral vectors into early gestation mice effectively targets skin stem cells for potential gene therapy.

Controlling cellular changes can enable safe rejuvenation without cancer risk.

CD34⁺ cells help heal damaged limbs by promoting blood vessel growth.

Biomaterials can help heal wounds without scars and regenerate skin features.

Improving CRISPR/Cas systems can make gene editing more efficient and precise.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Genetically modified stem cells from human hair follicles can lower blood sugar and increase survival in diabetic mice.

ABCD1 gene mutations cause adrenomyeloneuropathy, leading to symptoms like limb weakness and spasticity, with management focusing on rehabilitation and spasticity treatment.

Mechanosensory neurons adapt to different skin types after birth.

Metabolic syndrome is linked to skin diseases, requiring integrated treatment and monitoring.

The enzyme RDH12 plays a role in vision and retinal disease, with mutations leading to early onset visual loss and blindness, but the exact disease mechanism is unclear and there are no treatments yet.

IGFBP5 may be a potential target for Parkinson's treatment by reducing neuron death.

Keratin 6A increases skin inflammation, suggesting it could be a target for treating certain skin diseases.

New methods improve stem cell delivery for heart disease, but challenges remain.

ELIP-based CRISPR delivery improves heart disease gene editing but needs more testing.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

5α-reductase 2 is crucial for stress response in male rats.

3D bioprinted lung cancer models in a mouse-like structure offer a better way to study radiation effects without using live animals.